Results 1 to 10 of about 15,577 (237)

Azithromycin suppresses Th1- and Th2-related chemokines IP-10/MDC in human monocytic cell line

Journal of Microbiology, Immunology and Infection, 2019
Background: Cytokines and chemokines play critical roles in the pathogenesis of asthma. Azithromycin, a macrolides, is frequently used in asthmatic children with lower respiratory tract infection and is reported having anti-inflammatory and ...
Chang-Hung Kuo, Min-Sheng Lee, Hsuan-Fu Kuo, Yi-Ching Lin, Chih-Hsing Hung   +4 more
doaj   +1 more source

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial. [PDF]

PLoS Neglected Tropical Diseases, 2018
BACKGROUND:Mass azithromycin distribution reduces under-5 child mortality. Trachoma control programs currently treat infants aged 6 months and older. Here, we report findings from an infant adverse event survey in 1-5 month olds who received azithromycin
Catherine E Oldenburg, Ahmed M Arzika, Ramatou Maliki, Mohamed Salissou Kane, Elodie Lebas, Kathryn J Ray, Catherine Cook, Sun Y Cotter, Zhaoxia Zhou, Sheila K West, Robin Bailey, Travis C Porco, Jeremy D Keenan, Thomas M Lietman, MORDOR Study Group   +14 more
doaj   +1 more source

Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan

Microbiology Spectrum
The latest guidelines include azithromycin as a preferred regimen for treating Mycobacterium avium complex (MAC) pulmonary disease. However, serially collected susceptibility data on clinical MAC isolates are limited, and no breakpoints have been ...
Yoshifumi Uwamino, Wataru Aoki, Rika Inose, Yuka Kamoshita, Kei Mikita, Ho Namkoong, Tomoyasu Nishimura, Hiromichi Matsushita, Naoki Hasegawa   +8 more
doaj   +1 more source

Long-term Azithromycin in Children With Bronchiectasis Unrelated to Cystic Fibrosis

, 2023
Background: Following evidence from randomized controlled trials, patients with bronchiectasis unrelated to cystic fibrosis receive long-term azithromycin to reduce acute respiratory exacerbations.
Yerkovich, S, Dharmage, SC, Valery, PC, Morris, PS, Patricia C. Valery, Vicendese, D, Peter S. Morris, Byrnes, CA, Don Vicendese, Catherine A. Byrnes, Keith Grimwood, Anne B. Chang, Grimwood, K, Stephanie Yerkovich, Chang, AB, Shyamali C. Dharmage   +15 more
core   +1 more source

Azithromycin Prevents Pregnancy Loss: Reducing the Level of Tumor Necrosis Factor-Alpha and Raising the Level of Interleukin-10 in Rats

Mediators of Inflammation, 2013
The aim of this study was to determine the effect of azithromycin on LPS-induced pregnancy loss. Thirty-six pregnant female Wistar rats were divided into 4 equal groups as follows: control group, where 0.3 mL of normal saline solution was administered ...
Ayse Er
doaj   +1 more source

Creation of an assessment system for measuring the bitterness of azithromycin-containing reverse micelles

Asian Journal of Pharmaceutical Sciences, 2018
We aimed to develop a novel method for assessing the bitterness of azithromycin-containing reverse micelles (AM-containing RMs). Azithromycin-containing reverse micelles were prepared by processing Lipoid E80 and medium chain triglycerides via a freeze ...
Ri Huang, Yadan Zhang, Tao Wang, Liao Shen, Zhen Zhang, Yang Wang, Dongqin Quan   +6 more
doaj   +1 more source

Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial

Malaria Journal, 2021
Background Azithromycin has recently been shown to reduce all-cause childhood mortality in sub-Saharan Africa. One potential mechanism of this effect is via the anti-malarial effect of azithromycin, which may help treat or prevent malaria infection. This
Boubacar Coulibaly, Ali Sié, Clarisse Dah, Mamadou Bountogo, Mamadou Ouattara, Adama Compaoré, Moustapha Nikiema, Jérôme Nankoné Tiansi, Nestor Dembélé Sibiri, Jessica M. Brogdon, Elodie Lebas, Thuy Doan, Travis C. Porco, Thomas M. Lietman, Catherine E. Oldenburg   +14 more
doaj   +1 more source

Focus on azithromycin [PDF]

, 2021
Azithromycin is a second-generation macrolide that was developed in the early 1980s as a semi-synthetic derivative of erythromycin. This broad-spectrum antibiotic is known for its activity against some Gram-negative organisms such as H.
Padayachee, N., Milne, M, Schellack, Natalie   +2 more
core   +1 more source

Impact of prophylactic oral azithromycin during labor on Azithromycin Resistance (AMR) in nasal Staphylococcus aureus and Streptococcus pneumoniae in women and infants in the multi-country Azithromycin Prevention in Labor Use Study (A-PLUS).

PLoS ONE
BackgroundProphylactic oral azithromycin vs. placebo reduced maternal, but not neonatal, mortality/sepsis in the A-PLUS Randomized Trial. While prophylactic intrapartum azithromycin reduces maternal mortality/sepsis, it may promote antimicrobial ...
Patricia L Hibberd, Jean H Kim, Marissa Trotta, Sixto M Leal, Anna Aceituno, Doyle V Ward, Archana Patel, Akila Subramaniam, Waldemar A Carlo, Imran Ahmed, Sarah Saleem, Sk Masum Billah, Rashidun Haque, Manolo Mazariegos, Fabian Esamai, Manjunath S Somannavar, Shivaprasad S Goudar, Elwyn Chomba, Muska Mwenchanya, Adrien Lokangaka, Antoinette Tshefu, Robert L Goldenberg, Melissa Bauserman, Nancy F Krebs, Sherri Bucher, Richard J Derman, William A Petri, Marion Koso-Thomas, Denise C Babineau, Elizabeth M McClure, Alan T N Tita   +30 more
doaj   +1 more source

Azithromycin and the Outcome of Treated COVID-19 Patients: A Hospital-Based Study

Journal of Midwifery, 2022
COVID-19 is an infectious disease that has been declared a pandemic. Currently, there is no validated pharmacological treatment for use in COVID-19 disease and is still in the clinical trial stage.
Elly Usman
doaj   +1 more source